Genitourinary Cancer,Prostate Cancer Efficacy and Safety of Pembrolizumab and Docetaxel for mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer TALA Efficacy vs. Placebo with ENZA in First-Line mCRPC Treatment Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Interim Analysis 2 of NIRA + AAP for Treating mCRPC Patients Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Overall Survival of Abi+Ola vs. Abi+Pbo in 1st Line mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Darolutamide vs. Docetaxel for Treating mHSPC by Disease Volume and Risk Mar 27, 2023
Genitourinary Cancer,Prostate Cancer First-Line mCRPC Therapy After Apa Treatment Progression in Patients Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Rucaparib for Metastatic Prostate Cancer: Promising rPFS Treatment Results Mar 27, 2023
